Pancreatic Cancer Chemoprevention: Challenges and Opportunities

Curr Med Chem. 2018;25(22):2532-2534. doi: 10.2174/092986732522180704091601.

Authors

Altaf Mohammed¹, Chinthalapally V Rao²

Affiliations

¹ Chemopreventive Agent Development Research Group (CADRG) Division of Cancer Prevention National Cancer Institute Rockville, MD 20850, United States.
² Center for Cancer Prevention and Drug Development (CCPDD) Stephenson Cancer Center, Medical Oncology University of Oklahoma Health Sciences Center Oklahoma City, OK 73104, United States.

PMID: 30014794
DOI: 10.2174/092986732522180704091601

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Antineoplastic Agents / therapeutic use*
Chemoprevention*
Humans
Pancreatic Neoplasms / diagnosis
Pancreatic Neoplasms / mortality
Pancreatic Neoplasms / prevention & control*
Prognosis
Survival Rate

Substances

Antineoplastic Agents